Cancer
| 4 min read
Pharma deals, FDA review hurdles, and more led the news this week.
Available on Demand
Gain insight into how microbiome research is advancing the understanding of cancer biology and therapeutic outcomes.
| 3 min read
Scientists at Johns Hopkins used a whole-body imaging technique to track where therapeutic cells go after injection
| 3 min read
Trained on more than 30,000 tumor genomes, MutationProjector offers drug developers a broader framework for connecting cancer genetics to therapy outcomes.
| 3 min read
As the field moves from fecal transplants toward defined bacterial consortia, the technical gaps in design, analytics, and co-cultivation are coming into sharper focus.
| 5 min read
Researchers identify a slow-cycling, therapy-tolerant state in breast cancer cells linked to Rac1 signaling and late metastatic relapse.
| 3 min read
New findings suggest that the location of mRNA expression in the body plays a critical role in shaping T cell responses, opening the door to more precise and effective mRNA-based treatments.
| 4 min read
Living drugs are blurring the line between therapy and biology, challenging decades of assumptions about how medicines are made and controlled.
| 4 min read
Researchers have identified a previously unrecognized inflammatory pathway driven by damaged mitochondria in pancreatic cancer cells, revealing a potential vulnerability.
| 5 min read
Researchers identified a mitochondrial enzyme that shields lung cancer cells from a radiation-induced cell death process — and then found that an existing arthritis drug can disable that shield.
| 3 min read
Preclinical data show a first-in-class transdermal bicarbonate therapy increases tumor pH, reactivates T cells and slows bladder tumor growth in mice.
| 4 min read
Accent Therapeutics advances a KIF18A inhibitor, leveraging genomic instability to create druggable dependencies.
